T Schiff Selected Research

Sensodyne

1/2011	Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.
6/2000	Desensitizing efficacy of a new dentifrice containing 5.0% potassium nitrate and 0.454% stannous fluoride.
1/2000	A randomized clinical trial of the desensitizing efficacy of three dentifrices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Schiff Research Topics

Disease

3	Dentin Sensitivity 01/2011 - 06/2000
3	Hypersensitivity (Allergy) 01/2011 - 01/2000
1	Necrosis 06/2002
1	Osteonecrosis (Kienbock's Disease) 06/2002

Drug/Important Bio-Agent (IBA)

4	Dentifrices (Dentifrice)IBA 01/2011 - 01/2000
3	SensodyneIBA 01/2011 - 01/2000
3	fluorophosphate (sodium monofluorophosphate)FDA Link 01/2011 - 06/2000
3	colgate sensitiveIBA 01/2011 - 01/2000
2	FluoridesIBA 01/2011 - 01/2009
2	Arginine (L-Arginine)FDA Link 01/2011 - 01/2009
2	Calcium Carbonate (Limestone)FDA Link 01/2011 - 01/2009
2	Sodium Fluoride (Ossin)FDA Link 01/2011 - 01/2000
2	ToothpastesIBA 01/2009 - 01/2000
2	potassium nitrate (saltpeter)IBA 06/2000 - 01/2000
2	Tin Fluorides (Floran)FDA LinkGeneric 06/2000 - 01/2000
2	Silicon Dioxide (Silica)FDA LinkGeneric 06/2000 - 01/2000
1	strontium acetateIBA 01/2011
1	OlaflurIBA 01/2011
1	NitrogenIBA 06/2002
1	dihydrate dibasic calcium phosphate (brushite)IBA 06/2000

Therapy/Procedure

1	Bone Transplantation (Bone Grafting) 06/2002